|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4341 USD | -16.43% |
|
-16.44% | -3.53% |
| 04-06 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 11-12 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.9M 1.76M 1.64M 3.09M 206M 3.14M 21.08M 8.18M 101M 8.17M 7.99M 354M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.8M 10.89M 10.16M 19.15M 1.27B 19.49M 131M 50.73M 629M 50.65M 49.52M 2.19B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.86% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | -16.43% | ||
| 1 week | -16.44% | ||
| 1 month | +17.32% | ||
| 3 months | +44.70% | ||
| 6 months | -3.53% | ||
| Current year | -3.53% |
| 1 week | 0.43 |  | 0.52 |
| 1 month | 0.39 | | 0.52 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.21 | | 0.57 |
| 3 years | 0.12 | | 1.04 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 15/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 30/03/2016 |
| Director of Finance/CFO | 46 | 20/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Vied
BRD | Director/Board Member | 65 | 26/01/2015 |
David Mulder
BRD | Director/Board Member | 65 | 16/05/2016 |
Matthew Custer
BRD | Director/Board Member | 43 | 15/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/09/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 27/08/25 | Free | Director | 50,000 | 0.6987% | ||
| 27/08/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -16.43% | -16.44% | +29.97% | -49.52% | 3.77M | |
| -2.48% | +8.34% | +53.87% | +155.75% | 1,097B | |
| -1.76% | +6.23% | +66.27% | +53.44% | 622B | |
| -1.05% | +7.19% | +35.57% | +86.77% | 449B | |
| +0.83% | +4.18% | +31.11% | +23.88% | 334B | |
| -1.38% | +3.75% | +39.33% | +25.04% | 294B | |
| +0.30% | +2.56% | +31.62% | +40.64% | 286B | |
| -0.10% | +2.23% | -28.43% | -42.77% | 213B | |
| +0.44% | +4.35% | +29.69% | +63.10% | 195B | |
| +0.01% | +1.03% | +13.95% | +63.93% | 157B | |
| Average | -2.13% | +5.05% | +30.29% | +42.03% | 364.67B | |
| Weighted average by Cap. | -1.12% | +7.04% | +40.91% | +77.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 20.19M 18.64M 17.39M 32.76M 2.18B 33.35M 224M 86.81M 1.08B 86.68M 84.74M 3.75B | 24.22M 21.2M 19.57M 18.25M 34.39M 2.29B 35M 235M 91.11M 1.13B 90.98M 88.94M 3.94B |
| Net income | -5.27M -4.61M -4.26M -3.97M -7.48M -498M -7.61M -51.05M -19.82M -246M -19.79M -19.35M -856M | -3.2M -2.8M -2.59M -2.41M -4.55M -303M -4.63M -31.04M -12.05M -149M -12.03M -11.76M -521M |
| Net Debt | 10.2M 8.93M 8.24M 7.69M 14.48M 964M 14.74M 98.83M 38.37M 476M 38.31M 37.45M 1.66B | 11.31M 9.9M 9.14M 8.52M 16.06M 1.07B 16.34M 110M 42.54M 528M 42.48M 41.53M 1.84B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/06/26 | US$0.4341 | -16.43% | 1,000 |
| 25/06/26 | US$0.5194 | -0.02% | 1,500 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
